BCL6 and B-cell non-Hodgkin lymphoma: Previous studies have demonstrated that HBV infection of B cell lymphomas can alter B-cell-specific signaling pathways by enhancing overall gene mutations, including CD70 [26, 27], or by increasing non-silent mutations or gene translocations, such as BCL6 [28].